Sept. 30, 2013 – Pharmaceutical companies that develop mobile applications should pay close attention to the details and examples listed in the FDA’s final guidance on mobile medical applications (MMAs), which was issued Sept. 25. The final guidance on Mobile Medical Applications – a primer on how the agency plans to approach software programs that […]
Read more